Physician profile
Zhen Fan
NPI 1184876179
$22,797.21
in general payments reported to CMS, 2019-2025
20 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $879 · 2021: $561 · 2022: $782 · 2023: $672 · 2024: $8,893 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $18K · Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $18,106.66 |
| Food and Beverage | $1,852.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $18,159.68 | 2024-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Medtronic, INC. | $1,181.04 | 2021-2025 | Venaseal, Inceptiv, Dextile |
| Davol INC. | $1,045.51 | 2019-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $884.48 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $542.71 | 2020-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic Vascular, INC. | $350.47 | 2019-2020 | |
| Tactile Systems Technology INC | $150.38 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Galderma Laboratories, L.P. | $147.38 | 2021-2022 | |
| Acera Surgical, INC. | $84.38 | 2025 | Restrata Wound Matrix |
| Venclose INC. | $43.93 | 2020 | |
| Shire North American Group INC | $39.92 | 2019 | |
| Ethicon US, LLC | $27.21 | 2021 | |
| Acell, INC. | $24.67 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.49 | 2025 | Exparel |
| Organogenesis INC. | $20.21 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $18.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.75 | 2023 | Seglentis |
| Pharmacyclics LLC, An Abbvie Company | $14.92 | 2019 | |
| Allergan, INC. | $11.92 | 2022 | |
| Merck Sharp & Dohme LLC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhen Fan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.